Latest updates for Pharma
Fresh curated links around pharma are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- <![CDATA[Pharma M&A Roundup: Chemomab Therapeutics Enters Merger Agreement with Scipher Medicine, Teva and Polpha
- <![CDATA[Pharma at a Political Crossroads]]>
- <![CDATA[Rethinking Pharma's Go-to-Market Formula]]>
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
<![CDATA[Additive Manufacturing's Application in Pharma and Biotech]]>
<![CDATA[Pharma Funding Roudup: Kardigan Announces $400 Million Initial IPO, cAMPfield Launches with $180 million Ser...
<![CDATA[Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio]]>
<![CDATA[Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI]]>
<![CDATA[How Pharma is Adjusting Strategies for Changing Dynamics at FDA]]>
<![CDATA[Pharma M&A Roundup: Servier Acquiring Edgewise Therapeutics' Muscular Dystrophy Business, Hanmi Enters L...
<![CDATA[Pharma M&A Roundup: Protillion Biosciences Enters Drug Discovery Collaboration with Merck, Jazz Pharmace...
<![CDATA[Parabilis Medicines Raises $670 Million in Initial Public Offering ]]>
<![CDATA[Insilico Medicine Enters $2.5 Billion Alliance with Bora Pharmaceuticals ]]>
Top Pharma Stocks Based on Big Data: Returns up to 18.5% in 3 Days
Package Name: Pharma Stocks Forecast Recommended Positions: Long Forecast Length: 3 Days (7/6/26 - 7/9/26) I Know First Average: 4.76% Read The Full Forecast...
<![CDATA[Improving Global Pharma Operations with Data]]>
<![CDATA[The Rise of Direct-to-Patient Models in Pharma: Opportunities and Risks in Bypassing Traditional Distributio...
<![CDATA[Pharma M&A Roundup: Gilead Sciences Expands Collaboration with World Health Organization, Johnson &...
<![CDATA[Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Joh...
End-to-end: Curia drives supply and scale for steroid and hormonal therapies
Explore how Curia tackles steroid manufacturing complexity, from early development to scaled, end-to-end commercial supply. The post End-to-end: Curia drives supply and scale for s...
<![CDATA[Pharmaceutical Executive Daily: FDA Approves Ennumo]]>
<![CDATA[The Changing Reality of Pharmaceutical Commercialization in a Cold Chain-Driven Market]]>
<![CDATA[AbbVie to Acquire Apogee Therapeutics in $10 Billion Deal]]>
<![CDATA[How Regulatory Stringency, Demand Shocks, and Repurposing Reshape Biopharma Strategy in 2026]]>
<![CDATA[AlzeCure Pharma Enters $2.2 Billion Licensing and Collaboration Agreement with QuantumCell ApS]]>
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.